Skip to main content

Table 3 Sensitivity analysis

From: Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis

Excluded study

Pooled WMD for FPG (mmol/l)

Pooled WMD for HbA1c (%)

Pooled WMD for total cholesterol (mmol/l)

Pooled WMD for LDL (mmol/l)

Pooled WMD for HDL (mmol/l)

Pooled WMD for triglycerides (mmol/l)

Pooled WMD for BMI (kg/m2)

Pooled WMD for weight (kg)

Berhanu et al. [13]

− 1.678 (− 2.128; − 1.228)

− 1.041 (− 1.248; − 0.835)

0.091 (− 0.111; 0.294)

0.051 (− 0.042; 0.143)

0.197 (0.067; 0.327)

− 0.300 (− 0.653; 0.054)

1.148 (0.368; 1.928)

1.747 (0.657; 2.837)

Belfort et al. [14]

− 1.568 (− 2.016; − 1.121)

− 1.105 (− 1.312; − 0.897)

0.121 (− 0.011; 0.253)

0.054 (− 0.035; 0.144)

0.199 (0.068; 0.329)

− 0.267 (− 0.614; 0.080)

  

DeFronzo et al. [16]

− 1.608 (− 2.284; − 0.933)

   

0.172 (0.131; 0.213)

− 0.136 (− 0.244; − 0.028)

1.091 (0.060; 2.121)

1.396 (0.559; 2.233)

DeFronzo et al. [17]

− 1.642 (− 2.152; − 1.131)

     

1.026 (0.108; 1.944)

 

Mattoo et al. [15]

− 1.560 (− 2.005; − 1.114)

− 1.115 (− 1.324; − 0.906)

 

0.086 (0.001; 0.171)

0.196 (0.065; 0.327)

   

Rosenstock et al. (15 mg) [18]

− 1.517 (− 1.962; − 1.071)

− 1.093 (− 1.316; − 0.870)

 

0.043 (− 0.056; 0.143)

0.191 (0.059; 0.323)

− 0.308 (− 0.665; 0.049)

  

Rosenstock et al. (30 mg) [18]

− 1.464 (− 1.902; − 1.026)

− 1.068 (− 1.295; − 0.842)

 

0.046 (− 0.077; 0.169)

0.186 (0.054; 0.318)

− 0.286 (− 0.649; 0.077)

  

Davidson et al. (30 mg) [19]

− 1.526 (− 1.971; − 1.080)

− 1.074 (− 1.301; − 0.847)

 

0.039 (− 0.060; 0.137)

0.185 (0.051; 0.319)

− 0.296 (− 0.687; 0.095)

  

Davidson et al. (45 mg) [19]

− 1.470 (− 1.905; − 1.036)

− 1.048 (− 1.258; − 0.838)

 

0.039 (− 0.059; 0.137)

0.177 (0.043; 0.312)

− 0.293 (− 0.689; 0.103)

  

Goldberg et al. [3]

− 1.520 (− 1.954; − 1.086)

− 1.122 (− 1.325; − 0.920)

0.077 (− 0.029; 0.183)

0.024 (− 0.057; 0.104)

0.196 (0.066; 0.325)

− 0.228 (− 0.585; 0.130)

 

1.708 (0.364; 3.053)

Panikar et al. (7.5 mg) [22]

 

− 1.083 (− 1.288; − 0.877)

    

1.150 (0.385; 1.915)

1.915 (0.786; 3.043)

Panikar et al. (15 mg) [22]

 

− 1.084 (− 1.290; − 0.878)

    

1.137 (0.373; 1.902)

1.873 (0.743; 3.004)

Panikar et al. (30 mg) [22]

 

− 1.084 (− 1.289; − 0879)

    

1.120 (0.356; 1.884)

1.829 (0.649; 2.963)

Xu et al. [20]

− 1.509 (− 1.950; − 1.067)

− 1.049 (− 1.261; − 0.837)

0.199 (0.124; 0.275)

0.067 (− 0.024; 0.158)

0.192 (0.059; 0.326)

− 0.276 (− 0.633; 0.082)

1.412 (1.335; 1.488)

2.097 (1.101; 3.092)

Yoshii et al. [25]

   

0.088 (0.003; 0.172)

0.196 (0.065; 0.327)

   

Bolli et al. [12]

− 1.538 (− 1.984; − 1.092)

− 1.045 (− 1.254; − 0.836)

     

1.613 (0.341; 2.885)

Kodama et al. [23]

 

− 1.141 (− 1.339; − 0.943)

 

0.057 (− 0.033; 0.148)

0.194 (0.063; 0.324)

  

1.786 (0.689; 2.884)

Shah et al. [24]

 

− 1.138 (− 1.334; − 0.941)

    

1.054 (0.132; 1.977)

1.711 (0.619; 2.803)

Gerber et al. (30 mg) [21]

− 1.462 (1.857; − 1.067)

− 1.086 (− 1.290; − 0.882)

0.124 (− 0.001; 0.249)

0.055 (− 0.034; 0.143)

0.192 (0.065; 0.320)

− 0.263 (− 0.595; 0.068)

 

1.728 (0.625; 2.830)

Gerber et al. (30/45 mg) [21]

− 1.516 (− 1.956; − 1.075)

− 1.086 (− 1.290; − 0.882)

0.123 (− 0.003; 0.248)

0.055 (− 0.033; 0.143)

0.192 (0.065; 0.319)

− 0.266 (− 0.597; 0.065)

 

1.728 (0.627; 2.828)

Gerber et al. (45 mg) [21]

− 1.545 (− 1.993; − 1.097)

− 1.087 (− 1.290; − 0.883)

0.123 (− 0.003; 0.249)

0.055 (− 0.033; 0.143)

0.195 (0.066; 0.323)

− 0.267 (− 0.599; 0.065)

 

1.729 (0.632; 2.827)